Moreover, the IFN signature observed in SLE patients leads circulating monocytes to differentiate into potent antigen-presenting dendritic cells (DCs) with an increased capacity to orchestrate T and B cell responses [129]. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.